comparemela.com

Latest Breaking News On - Immunotech inc key - Page 1 : comparemela.com

DGAP-News: AIM ImmunoTech Inc: AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 Long Haulers

DGAP-News: AIM I . DGAP-News: AIM ImmunoTech Inc: AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 Long Haulers vom 24.12.2020, 14:15 Uhr Bild: pixabay.com DGAP-News: AIM ImmunoTech Inc / Key word(s): Miscellaneous AIM ImmunoTech Inc: AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 Long Haulers 24.12.2020 / 14:15 The issuer is solely responsible for the content of this announcement. AIM ImmunoTech Announces that the ME/CFS Clinical Trial of its Drug Ampligen is Open for Enrollment to COVID-19 Long Haulers Institutional Review Board Authorizes Solicitation for Enrollment of Subjects

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.